Advertisement

Topics

Albireo nets $48.7mm in public stock sale

19:41 EDT 25 May 2017 | Elsevier Business Intelligence

Albireo Pharma Inc. (primarily develops liver disease treatments; also has GI projects) netted $48.7mm through a public offer...

Original Article: Albireo nets $48.7mm in public stock sale

NEXT ARTICLE

More From BioPortfolio on "Albireo nets $48.7mm in public stock sale"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...